Article Details

eureKARE invests in Coave Therapeutics as part of its €33 million Series B round

Retrieved on: 2021-07-21 06:00:00

Tags for this article:

Click the tags to see associated articles and topics

eureKARE invests in Coave Therapeutics as part of its €33 million Series B round. View article details on hiswai:

Excerpt

... generation biotechnology companies in the disruptive fields of the microbiome and synthetic biology, today announces its fourth portfolio investment ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up